Scarica l'app Stockscreener
0.4295
1.30%
0.0055
Dopo l'orario di chiusura:
.43
0.0005
+0.12%
Precedente Chiudi:
$0.424
Aprire:
$0.389
Volume 24 ore:
92,454
Relative Volume:
0.95
Capitalizzazione di mercato:
$2.99M
Reddito:
-
Utile/perdita netta:
$-2.66M
Rapporto P/E:
-0.7157
EPS:
-0.6001
Flusso di cassa netto:
$-2.83M
1 W Prestazione:
+24.49%
1M Prestazione:
+2.26%
6M Prestazione:
-47.35%
1 anno Prestazione:
-55.26%
Intervallo 1D:
$0.37
$0.4638
Intervallo di 1 settimana:
$0.3456
$0.4638
Portata 52W:
$0.345
$1.41
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Nome
Xortx Therapeutics Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare XRTX vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.4295 | 2.99M | 0 | -2.66M | -2.83M | -0.6001 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Xortx Therapeutics Inc Borsa (XRTX) Ultime notizie
XRTX Technical Analysis & Stock Price Forecast - Intellectia AI
XORTX Therapeutics Inc.: Dividend historical data and projections - MarketScreener
XORTX Therapeutics Confirms Share Consolidation Will Occur April 6, 2026 - MarketScreener
XORTX Therapeutics to consolidate shares 1-for-5 effective April 6, 2026 - MarketScreener
Xortx Therapeutics To Consolidate Shares 1-For-5 Effective April 6, 2026 - TradingView
XORTX Confirms Effective Date of Share Consolidation - Caledonian Record
XORTX (XRTX) wins approvals for 1-for-5 share consolidation effective April 6, 2026 - Stock Titan
Every 5 XORTX shares become 1 on April 6 after approvals - Stock Titan
XRTX: Static price chart | XORTX Therapeutics Inc. | CA98420Q3061 - marketscreener.com
XORTX Therapeutics Inc. Stock (XRTX)Quote Toronto S.E. - marketscreener.com
What is the target price for XORTX Therapeutics Inc stockInsider Selling & Precise Trade Entry Recommendations - baoquankhu1.vn
Is XORTX Therapeutics Inc a speculative investmentMarket Sentiment Review & Consistent Profit Trade Alerts - baoquankhu1.vn
XORTX shareholders approve up-to-5-for-1 share consolidation to meet Nasdaq rules - MSN
XORTX Shareholders Approve Governance Measures and Share Consolidation at Annual Meeting - The Globe and Mail
XORTX Delays Effective Date of One-for-Five Share Consolidation - The Globe and Mail
XORTX (NASDAQ: XRTX) shareholders approve board slate and consolidation - Stock Titan
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
XORTX Therapeutics (NASDAQ: XRTX) shareholders approve board, stock plan and share consolidation - Stock Titan
Update Recap: Does XORTX Therapeutics Inc have declining or rising EPS2026 Reactions & Entry and Exit Point Strategies - baoquankhu1.vn
XORTX Announces Results of Annual and Special Meeting of Shareholders - Caledonian Record
XORTX (NASDAQ: XRTX) moves 1-for-5 share consolidation to April 6 - Stock Titan
XORTX Announces Change of Effective Date of Share Consolidation - MarketScreener
XORTX's 5-for-1 share consolidation is now scheduled for April 6 - Stock Titan
Xortx Therapeutics Brief: Board Approved Consolidating Common Shares On Basis of One Post-Consolidation Share For Every Five, Effective March 27, 2025 - MarketScreener
Investment Recap: Is XORTX Therapeutics Inc in a long term uptrendMarket Growth Report & Risk Controlled Daily Plans - baoquankhu1.vn
XORTX Announces Share Consolidation - marketscreener.com
XORTX Shareholders Approve Reverse Split to Preserve Nasdaq Listing - The Globe and Mail
XORTX shrinks shares from 6.96M to 1.39M to stay on Nasdaq - Stock Titan
XORTX Therapeutics Brief: Reporting Shareholders Approved Share Consolidation at AGM; On Basis of Up to 5 Pre-consolidation Common Shares For Every 1 Post-consolidation Common Share - MarketScreener
XORTX Therapeutics (XRTX) wins shareholder approval for up to 5-for-1 share consolidation - Stock Titan
XORTX Reports that Shareholders Approved the Share Consolidation at the Annual General Meeting - globenewswire.com
XORTX needs its stock above $1. Shareholders approved a 5-for-1 consolidation - Stock Titan
If You Invested $1,000 in Xortx Therapeutics Inc (XRTX) - Stock Titan
Aug Highlights: Does XORTX Therapeutics Inc. have declining or rising EPS2026 Price Action Summary & Verified Chart Pattern Signals - baoquankhu1.vn
XRTX SEC FilingsXortx Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
XRTX: Net loss improved to US$2.66M in 2025 as late-stage clinical programs advanced and cash reserves declined - TradingView
XORTX Therapeutics (NASDAQ: XRTX) outlines losses and drug pipeline - stocktitan.net
XORTX Ties Board Shake-Up to Financing Ahead of March 24 Shareholder Vote - The Globe and Mail
Whale Trades: Can XORTX Therapeutics Inc continue delivering strong returnsEarnings Performance Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
XORTX Reshapes Board to Meet Conditions for Planned Financing - The Globe and Mail
Aug Macro: Does XORTX Therapeutics Inc have pricing power2026 Breakouts & Breakdowns & Stepwise Trade Signal Implementation - baoquankhu1.vn
Xortx Therapeutics announces three new director nominees - TipRanks
XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders - markets.businessinsider.com
Street Watch: What is the cash position of XORTX Therapeutics Inc2026 Final Week & Trade Opportunity Analysis - baoquankhu1.vn
Pullback Watch: Is XORTX Therapeutics Inc a speculative investmentTrade Ideas & High Conviction Buy Zone Picks - baoquankhu1.vn
Proxy Advisers Back XORTX Share Consolidation Plan Ahead of March Vote - theglobeandmail.com
ISS backs XORTX (NASDAQ: XRTX) share consolidation ahead March 2026 vote - Stock Titan
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote "For" the Share Consolidation - Bitget
XORTX Brief: Reporting that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote "For" Share Consolidation - marketscreener.com
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation - marketscreener.com
Whats the RSI of XORTX Therapeutics Inc stockMarket Growth Report & Daily Profit Focused Stock Screening - baoquankhu1.vn
Xortx Therapeutics Inc Azioni (XRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):